US Patents rejects Teva's plea on Copaxone; Natco shares up

Hyderabad-based Natco markets Copaxone (Glatiramer Acetate) -- used in the treatment of relapsing-remitting multiple sclerosis -- in the US market.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news